Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.20
+0.90 (1.75%)
Apr 2, 2025, 1:30 PM CST

Pharmosa Biopharm Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
749.44974.06672.51461.46414.54
Upgrade
Short-Term Investments
869----
Upgrade
Cash & Short-Term Investments
1,618974.06672.51461.46414.54
Upgrade
Cash Growth
66.16%44.84%45.73%11.32%9672.18%
Upgrade
Accounts Receivable
4.65----
Upgrade
Other Receivables
6.691.470.290.310.15
Upgrade
Receivables
11.341.470.290.310.15
Upgrade
Inventory
24.7421.91---
Upgrade
Prepaid Expenses
27.2212.6711.6514.188.69
Upgrade
Other Current Assets
---0.024
Upgrade
Total Current Assets
1,6821,010684.45475.96427.37
Upgrade
Property, Plant & Equipment
315.06180.6130.1233.4440.86
Upgrade
Long-Term Investments
73.2671.2265.6961.660.91
Upgrade
Other Intangible Assets
0.660.090.150.18-
Upgrade
Other Long-Term Assets
92.8871.6218.9515.1914.13
Upgrade
Total Assets
2,1641,334799.37586.37543.27
Upgrade
Accounts Payable
0.680.59---
Upgrade
Accrued Expenses
61.5133.2412.2811.6610.43
Upgrade
Short-Term Debt
----61
Upgrade
Current Portion of Long-Term Debt
-1.263.528.4318.81
Upgrade
Current Portion of Leases
17.9824.697.196.86.43
Upgrade
Current Unearned Revenue
6.89----
Upgrade
Other Current Liabilities
29.0717.84.776.192.58
Upgrade
Total Current Liabilities
116.1377.5827.7733.0799.25
Upgrade
Long-Term Debt
-1.192.455.9614.83
Upgrade
Long-Term Leases
99.62117.238.0415.923.36
Upgrade
Long-Term Unearned Revenue
4.82----
Upgrade
Other Long-Term Liabilities
5.1----
Upgrade
Total Liabilities
225.66195.9938.2554.93137.44
Upgrade
Common Stock
645.43586.02554.67489.24402.5
Upgrade
Additional Paid-In Capital
1,439531.341,180-454.19
Upgrade
Retained Earnings
-146.3720.28-973.44-706.94-450.46
Upgrade
Comprehensive Income & Other
0.020.010.01749.13-0.41
Upgrade
Shareholders' Equity
1,9381,138761.12531.44405.83
Upgrade
Total Liabilities & Equity
2,1641,334799.37586.37543.27
Upgrade
Total Debt
117.6144.3721.1937.09124.43
Upgrade
Net Cash (Debt)
1,501829.69651.32424.37290.1
Upgrade
Net Cash Growth
80.89%27.39%53.48%46.28%-
Upgrade
Net Cash Per Share
11.877.326.615.006.09
Upgrade
Filing Date Shares Outstanding
129.09117.2110.9397.8549.99
Upgrade
Total Common Shares Outstanding
129.09117.2110.9397.8549.99
Upgrade
Working Capital
1,566932.53656.68442.89328.12
Upgrade
Book Value Per Share
15.019.716.865.438.12
Upgrade
Tangible Book Value
1,9371,138760.97531.25405.83
Upgrade
Tangible Book Value Per Share
15.019.716.865.438.12
Upgrade
Machinery
68.3427.1126.3717.0519.59
Upgrade
Construction In Progress
134.42----
Upgrade
Leasehold Improvements
28.8535.61---
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.